DK0414078T3 - Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater - Google Patents

Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater

Info

Publication number
DK0414078T3
DK0414078T3 DK90115444.3T DK90115444T DK0414078T3 DK 0414078 T3 DK0414078 T3 DK 0414078T3 DK 90115444 T DK90115444 T DK 90115444T DK 0414078 T3 DK0414078 T3 DK 0414078T3
Authority
DK
Denmark
Prior art keywords
disubstituted
quinolin
acid derivatives
phenylacetic acid
methoxy
Prior art date
Application number
DK90115444.3T
Other languages
English (en)
Inventor
Siegfried Dr Raddatz
Christian Dr Kohlsdorfer
Klaus Dr Mohrs
Reiner Pro Mueller-Peddinghaus
Pia Dr Theisen-Popp
Romanis Fruchtmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0414078T3 publication Critical patent/DK0414078T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
DK90115444.3T 1989-08-24 1990-08-11 Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater DK0414078T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3927931A DE3927931A1 (de) 1989-08-24 1989-08-24 Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Publications (1)

Publication Number Publication Date
DK0414078T3 true DK0414078T3 (da) 1994-08-15

Family

ID=6387762

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90115444.3T DK0414078T3 (da) 1989-08-24 1990-08-11 Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater

Country Status (20)

Country Link
US (1) US5126354A (da)
EP (1) EP0414078B1 (da)
JP (1) JPH0390063A (da)
KR (1) KR910004570A (da)
CN (1) CN1049657A (da)
AT (1) ATE106395T1 (da)
AU (1) AU632845B2 (da)
CA (1) CA2023776A1 (da)
DD (1) DD298921A5 (da)
DE (2) DE3927931A1 (da)
DK (1) DK0414078T3 (da)
ES (1) ES2054177T3 (da)
FI (1) FI904158A0 (da)
HU (1) HU208960B (da)
IE (1) IE903072A1 (da)
IL (1) IL95443A (da)
NZ (1) NZ234995A (da)
PH (1) PH27287A (da)
PT (1) PT95071A (da)
ZA (1) ZA906706B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204358A (en) * 1987-11-25 1993-04-20 Merck Frosst Canada, Inc. Hetaryl styryl quinolines as leukotriene inhibitors
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4128681A1 (de) * 1991-08-29 1993-03-04 Bayer Ag Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
CA2092152A1 (en) * 1992-03-23 1993-09-24 Azuma Igarashi Phenoxyacetic acid compounds and medical preparations containing them
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
EP2086531A4 (en) 2006-11-30 2009-09-30 Amira Pharmaceuticals Inc COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS
ES2878405T3 (es) 2014-02-04 2021-11-18 Bioscience Pharma Partners Llc Uso de inhibidores de flap para reducir la lesión mediada por neuroinflamación en el sistema nervioso central

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2046979B (en) * 1979-04-17 1983-05-18 Burroughs Corp Recording and replay apparatus employing rotary media
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
EP0349062A1 (en) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Quinoline ether alkanoic acid
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate

Also Published As

Publication number Publication date
IL95443A0 (en) 1991-06-30
NZ234995A (en) 1991-12-23
EP0414078A3 (en) 1992-03-11
DE59005899D1 (de) 1994-07-07
PT95071A (pt) 1991-04-18
DE3927931A1 (de) 1991-02-28
CN1049657A (zh) 1991-03-06
ZA906706B (en) 1991-06-26
IE903072A1 (en) 1991-02-27
EP0414078A2 (de) 1991-02-27
PH27287A (en) 1993-05-04
AU6108590A (en) 1991-02-28
FI904158A0 (fi) 1990-08-22
EP0414078B1 (de) 1994-06-01
JPH0390063A (ja) 1991-04-16
CA2023776A1 (en) 1991-02-25
DD298921A5 (de) 1992-03-19
US5126354A (en) 1992-06-30
AU632845B2 (en) 1993-01-14
HU208960B (en) 1994-02-28
ATE106395T1 (de) 1994-06-15
ES2054177T3 (es) 1994-08-01
IL95443A (en) 1994-06-24
HUT54989A (en) 1991-04-29
KR910004570A (ko) 1991-03-28
HU905304D0 (en) 1991-02-28

Similar Documents

Publication Publication Date Title
DE59005899D1 (de) Disubstituierte (Chinolin-2-yl-methoxy) phenylessigsäure-Derivate.
ATE89819T1 (de) Gegebenenfalls alpha-substituierte 4-(chinolin-2- yl-methoxy)phenylessigsaeuren und -ester.
SE8504720L (sv) Ny lekemedelsberedning
FI892603A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
DE59007437D1 (de) Cyclisch substituierte (Chinolin-2-yl-methoxy)phenyl-essigsäure-Derivate.
DE3775389D1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
AU7160887A (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
DE3688451D1 (de) Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.
DK37389D0 (da) Det svampedraebende antibiotikum isobongkrekinsyre, mikrobiologisk fremgangsmaade til dets fremstilling samt dets anvendelse som laegemiddel
ATE44734T1 (de) 4-phenylpropylindolderivate und ihre salze, verfahren zur herstellung, deren anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.
ATE50494T1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.